Integrated weight management
GLP-1 medications are transforming obesity and diabetes care, offering significant benefits such as weight loss, improved cardiovascular health and potential impact on other conditions.
However, they come with high costs and growing demand. Employer coverage and member demand are rising rapidly, with a 2000%1 increase in prescriptions since 2019 and 57%2 of large employers now covering GLP-1s for obesity treatment.
Smarter benefit design can help control costs and improve outcomes by supporting alternatives to long-term medication use, including fitness programs, nutrition education and reward programs.
Personalized, equitable access must be prioritized — using data to tailor care, address disparities and ensure benefits meet diverse member needs across risk profiles.
Webinar speakers:
- Dr. Lisa Latts, Chief Medical Officer of Whole Health Solutions, Optum
- Molly Henning, Senior Director of Strategy and Growth, Optum
- Dr. Frank Dumont, Executive Medical Director, Virta Health
Related healthcare insights
Article
As GLP-1 use surges, payers and employers need to include behavioral support, deprescription planning and long-term care to sustain outcomes.
Article
Learn how employers can tap best practices to ensure their health rewards and loyalty programs make a meaningful difference.
Article
The collision of chronic conditions and behavioral health challenges can’t always be stopped, but healthcare leaders can work to mitigate its impact.
- Prescriptions for Trendy Diabetes and Weight-Loss Drugs Increased Over 2,000% Since 2019 , published Feb 2024
- GLP-1 update: Coverage trends and market developments - WTW, published Sept 2025